Skip to content

A Preliminary Screening for the Prevalence of Monoclonal Gammapathy of Undetermined Significance in China

A Survey for the Prevalence of Monoclonal Gammapathy of Undetermined Significance in China

Status
Recruiting
Phases
Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-SIC-17011273
Enrollment
Unknown
Registered
2017-05-01
Start date
2017-05-16
Completion date
Unknown
Last updated
2017-05-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

MGUS

Interventions

5:none

Sponsors

Peking University People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 100 Years

Inclusion criteria

Inclusion criteria: aged more than or equal to 40 years old, Chinese population, inpatient

Exclusion criteria

Exclusion criteria: diagnosed with plasma cell dyscrasia other than "MGUS"

Design outcomes

Primary

MeasureTime frame
Damage related to MM;

Secondary

MeasureTime frame
Age, sex, et al.;

Countries

China

Contacts

Public ContactJin Lu

Peking University People's Hospital, Peking University Institute of Hematology

jin1lu@sina.com+86 13311491805

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026